Pharm
Erythromycin
search
Erythromycin
, Erythromycin Base
See Also
Macrolide
Erythromycin Ethyl Succinate
(EES)
Erythromycin Lactobionate
Indications
Major indications for Erythromycin
Chlamydia pneumoniae
Chlamydia trachomatis
Pneumonia
e or
Conjunctivitis
Pelvic infection in pregnancy
Legionella pneumophila
Mycoplasma pneumoniae
Bordetella pertussis
Corynebacterium diphtheriae
Campylobacter jejuni
Other organisms covered
Ureaplasma Urealyticum
Treponema pallidum
(
Syphilis
)
Staphylococcus
Streptococcus
Bacillus anthracis
Clostridium
species
Mechanism
See
Macrolide
Adverse Effects
Gastrointestinal upset
Nausea
Cholestatic
Jaundice
Multiple
Drug Interaction
s
Candida
Vaginitis
infection
Gram Negative
Folliculitis
Myasthenia Gravis
exacerbation
Hypertrophic Pyloric Stenosis
(age <45 days)
QT Prolongation
Class effect with
Macrolide
s
Three fold increased risk of
Sudden Cardiac Death
while on
Azithromycin
Higher risk with known
QTc Prolongation
,
Hypokalemia
,
Hypomagnesemia
, Class IA or III
Antiarrhythmic
s
Ray (2013) N Engl J Med 366(20): 1881-90 [PubMed]
Drug Interactions
See
Macrolide
Strong
CYP3A4
Inhibitor
Numerous
Drug Interaction
s
Warfarin
May increase INR
Pharmacokinetics
Half life: 1.5 hours
Dosing
See
Erythromycin Ethyl Succinate
(EES)
See
Erythromycin Lactobionate
See
Pertussis
Erythromycin Oral Preparations (Take with food to reduce GI Upset)
Erythromycin Base
Adult: Take 250 to 500 mg orally four times daily OR 333 mg orally three times daily
Child: Take 30 to 50 mg/kg/day divided four times daily
Erythromycin Ethyl Succinate
(EES)
Adult: 400 mg orally four times daily
Child: 30-50 mg/kg/day divided orally four times daily
Erythromycin
Parenteral
Preparation:
Erythromycin Lactobionate
Dose: 15 to 20 mg/kg/day IV divided every 6 hours
Maximum: 4 grams
Safety
Pregnancy Category B
Considered safe in
Lactation
Adverse Effects
Myasthenia Gravis
exacerbation
Hypertrophic Pyloric Stenosis
(age <45 days)
Strong
CYP3A4
Inhibitor
Numerous
Drug Interaction
s
Serious interactions resulting in death have occurred
Warfarin
May increase INR
QT Prolongation
Class effect with
Macrolide
s
Three fold increased risk of
Sudden Cardiac Death
while on
Azithromycin
Higher risk with known
QTc Prolongation
,
Hypokalemia
,
Hypomagnesemia
, Class IA or III
Antiarrhythmic
s
Ray (2013) N Engl J Med 366(20): 1881-90 [PubMed]
Resources
Erythromycin Base (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca1326d6-c5c6-4572-96b6-e56cd944799c
Type your search phrase here